Stay updated on TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.

Latest updates to the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding status notice and the earlier Revision: v3.4.1.SummaryDifference0.1%

- Check21 days agoChange DetectedA new global notice about government funding and operating status has been added to the top of the page, and the version number has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedAdded: Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. Deleted: Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check35 days agoChange DetectedA new publication citation was added to the Publications section: Pembrolizumab for Early-Stage Triple-Negative Breast Cancer—KEYNOTE-522 Japan Subgroup Analysis (Cancer Sci. 2026 Jan 14).SummaryDifference0.0%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4, indicating a minor site revision. No core content, study identifiers, or trial details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded extensive Locations sections with study sites across multiple regions (US states, Canadian provinces, Europe, Asia and Australia). Updated the page revision to v3.3.3.SummaryDifference2%

Stay in the know with updates to TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.